{"nct_id":"NCT04840901","title":"A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2021-06-02","start_date_type":"ACTUAL","primary_completion_date":"2022-02-11","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}